Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow-to-Debt Ratio
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥9.12 Million could theoretically repay 0% of its total liabilities (CN¥571.21 Million) in one year. Check Shenzhen Bioeasy Biotechnology Co. Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Shenzhen Bioeasy Biotechnology Co. Ltd. across 10 annual periods. Also explore 300942 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year debt coverage analysis for Shenzhen Bioeasy Biotechnology Co. Ltd.. For market capitalisation and broader financial context, see 300942 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.11x | CN¥66.87 Million | CN¥616.87 Million | ▲ +85.7% |
| 2024 | 0.06x | CN¥34.26 Million | CN¥586.92 Million | ▲ +179.5% |
| 2023 | -0.07x | CN¥-37.25 Million | CN¥507.61 Million | ▼ -115.3% |
| 2022 | 0.48x | CN¥152.55 Million | CN¥317.75 Million | ▼ -61.3% |
| 2021 | 1.24x | CN¥255.42 Million | CN¥205.94 Million | ▲ +102.0% |
| 2020 | 0.61x | CN¥63.79 Million | CN¥103.90 Million | ▼ -16.6% |
| 2019 | 0.74x | CN¥67.24 Million | CN¥91.35 Million | ▼ -5.7% |
| 2018 | 0.78x | CN¥57.93 Million | CN¥74.22 Million | ▲ +95.8% |
| 2017 | 0.40x | CN¥23.60 Million | CN¥59.19 Million | ▼ -25.5% |
| 2016 | 0.54x | CN¥36.31 Million | CN¥67.83 Million | — |